<code id='5D4D8ED3FC'></code><style id='5D4D8ED3FC'></style>
    • <acronym id='5D4D8ED3FC'></acronym>
      <center id='5D4D8ED3FC'><center id='5D4D8ED3FC'><tfoot id='5D4D8ED3FC'></tfoot></center><abbr id='5D4D8ED3FC'><dir id='5D4D8ED3FC'><tfoot id='5D4D8ED3FC'></tfoot><noframes id='5D4D8ED3FC'>

    • <optgroup id='5D4D8ED3FC'><strike id='5D4D8ED3FC'><sup id='5D4D8ED3FC'></sup></strike><code id='5D4D8ED3FC'></code></optgroup>
        1. <b id='5D4D8ED3FC'><label id='5D4D8ED3FC'><select id='5D4D8ED3FC'><dt id='5D4D8ED3FC'><span id='5D4D8ED3FC'></span></dt></select></label></b><u id='5D4D8ED3FC'></u>
          <i id='5D4D8ED3FC'><strike id='5D4D8ED3FC'><tt id='5D4D8ED3FC'><pre id='5D4D8ED3FC'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:889
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Menendez indictment could see pharma lose a key ally
          Menendez indictment could see pharma lose a key ally

          Sen.BobMenendez(D-N.J.)MichaelM.Santiago/GettyImagesWASHINGTON—WithmountingcallsforembattledSen.BobM

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Ionis drug prevents swelling attacks due to hereditary angioedema

          courtesyIonisPharmaceuticalsIonisPharmaceuticals,aCaliforniacompanythatpioneeredawholeclassofRNA-tar